User:Kashydan/Vasculogenic mimicry/Bibliography
You will be compiling your bibliography and creating an outline of the changes you will make in this sandbox.
Bibliography
[edit]- Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer. 2003 Jun;3(6):411-21. doi: 10.1038/nrc1092. PMID: 12778131.
- Scientific Review looking at role of VM in melanoma and its affect on tumor cell survival.
- Delgado-Bellido D, Serrano-Saenz S, Fernández-Cortés M, Oliver FJ. Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin. Mol Cancer. 2017 Mar 21;16(1):65. doi: 10.1186/s12943-017-0631-x. PMID: 28320399; PMCID: PMC5359927.
- Scientific Review with good basic descriptions of the role of VM and elaborates on what is known about the mechanism/pathway.
- Wei X, Chen Y, Jiang X, Peng M, Liu Y, Mo Y, Ren D, Hua Y, Yu B, Zhou Y, Liao Q, Wang H, Xiang B, Zhou M, Li X, Li G, Li Y, Xiong W, Zeng Z. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer. 2021 Jan 4;20(1):7. doi: 10.1186/s12943-020-01288-1. PMID: 33397409; PMCID: PMC7784348.
- Focuses on VM in cancer tme and explains mechanisms through which it is activated and maintained.
- Luo Q, Wang J, Zhao W, Peng Z, Liu X, Li B, Zhang H, Shan B, Zhang C, Duan C. Vasculogenic mimicry in carcinogenesis and clinical applications. J Hematol Oncol. 2020 Mar 14;13(1):19. doi: 10.1186/s13045-020-00858-6. PMID: 32169087; PMCID: PMC7071697.
- Sanhueza C, Wehinger S, Castillo Bennett J, Valenzuela M, Owen GI, Quest AF. The twisted survivin connection to angiogenesis. Mol Cancer. 2015 Nov 19;14:198. doi: 10.1186/s12943-015-0467-1. PMID: 26584646; PMCID: PMC4653922.
References
[edit]- Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer. 2003 Jun;3(6):411-21. doi: 10.1038/nrc1092. PMID: 12778131.
- Delgado-Bellido D, Serrano-Saenz S, Fernández-Cortés M, Oliver FJ. Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin. Mol Cancer. 2017 Mar 21;16(1):65. doi: 10.1186/s12943-017-0631-x. PMID: 28320399; PMCID: PMC5359927.
- Wei X, Chen Y, Jiang X, Peng M, Liu Y, Mo Y, Ren D, Hua Y, Yu B, Zhou Y, Liao Q, Wang H, Xiang B, Zhou M, Li X, Li G, Li Y, Xiong W, Zeng Z. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer. 2021 Jan 4;20(1):7. doi: 10.1186/s12943-020-01288-1. PMID: 33397409; PMCID: PMC7784348.
- Luo Q, Wang J, Zhao W, Peng Z, Liu X, Li B, Zhang H, Shan B, Zhang C, Duan C. Vasculogenic mimicry in carcinogenesis and clinical applications. J Hematol Oncol. 2020 Mar 14;13(1):19. doi: 10.1186/s13045-020-00858-6. PMID: 32169087; PMCID: PMC7071697.
- Sanhueza C, Wehinger S, Castillo Bennett J, Valenzuela M, Owen GI, Quest AF. The twisted survivin connection to angiogenesis. Mol Cancer. 2015 Nov 19;14:198. doi: 10.1186/s12943-015-0467-1. PMID: 26584646; PMCID: PMC4653922.
Outline of proposed changes
[edit]Introduction
[edit]- What is it
- What are its major roles
- What diseases and disorders has it been linked to
- IMAGE OF BASIC CELL VASCULATURE LABELED
Classifications
[edit]- Two types
- Tubular
- Patterned Matrix
- POTENTIAL IMAGE SHOW DIFFERENCE IF EXISTS
Pathophysiology
[edit]- Roles in disease
- OVERALL DIAGRAM SHOWING HOW IT PROMOTES TUMOR PROGRESSION ETC
Mechanisms and Pathways
[edit]- UNSURE IF FIGURE WILL BE TOO MUCH HERE
Cancer
[edit]- TABLE OR CHART OF CANCERS ITS BEEN DESCRIBED TO OCCUR IN
Therapeutics
[edit]- LINKS TO ANY EXISTING WIKI PAGES ON DRUGS ETC IN A CHART LISTING INFO